Roy Musil

Health Technology

Consumer Services

Finance

Profile

Roy Musil is Vice President of Quality and Regulatory Affairs for Althea Technologies, Inc. Most recently, he was Technology Manager of the Biopharmaceutical Technology Group for the Worldwide Supply Operations of Smithkline Beecham Plc.
Previously, he was Senior Manager of Process Development and Manufacturing for Immune Response Corp.
(now Orchestra Therapeutics, Inc.).
He began his career with the National Research Council.
Mr. Musil has 12 years of experience in the fields of recombinant protein and nucleic acid purification, pharmaceutical process development, technology transfer and final sterile filling operations.
He received a Master's degree in Biochemistry from Concordia University.

Former positions of Roy Musil

Companies	Position	End
The National Research Council The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC.	Corporate Officer/Principal	-
Smithkline Beecham Plc Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.	Chief Tech/Sci/R&D Officer	-
Orchestra Therapeutics, Inc. Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA.	Corporate Officer/Principal	-
Ajinomoto Althea, Inc. Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA.	General Counsel	-

See the detail of Roy Musil's experience

Training of Roy Musil

Concordia University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies